Precision Science - Ep 1 - Jim Woodgett

Join us for the pilot episode of Precision Science, a podcast where we discuss everything from single cell breakthroughs to equity in research. In the first episode of Precision Science, host Dr. Paola Marignani interviews Dr. Jim Woodgett, president and scientific director of the Terry Fox Research Institute, about cloning GSK-3α and β at the Ludwig Institute in London and then finding the kinase in Wnt and Notch signalling, cell differentiation, cancer, and the action of lithium. They discuss the limits of cell-line and mouse models, more selective drug delivery, patient-based research through the Marathon of Hope Cancer Centres Network, and the role of patient partners, including how an audience question in rural Nova Scotia led Marignani to redirect her lab and became the basis of her breast cancer program. They also cover science communication, reproducibility and bias, preprints versus for-profit journals, AI risks in scientific publishing and imaging, and advice for early-career scientists on mentorship, collaboration, lab management, and time off. #ScienceIsFun